O	0	12	Introduction	Introduction	NN	B-NP

O	13	18	Yeast	Yeast	NN	B-NP
O	19	29	infections	infection	NNS	I-NP
O	30	35	cause	cause	VBP	B-VP
O	36	47	significant	significant	JJ	B-NP
O	48	57	mortality	mortality	NN	I-NP
O	58	60	in	in	IN	B-PP
O	61	71	critically	critically	RB	B-NP
O	72	75	ill	ill	JJ	I-NP
O	76	79	and	and	CC	I-NP
O	80	97	immunocompromised	immunocompromised	JJ	I-NP
O	98	106	patients	patient	NNS	I-NP
O	106	107	.	.	.	O

O	108	110	In	In	IN	B-PP
O	111	121	particular	particular	JJ	B-NP
O	121	122	,	,	,	O
O	123	130	Candida	Candida	NNP	B-NP
O	131	138	species	specie	NNS	I-NP
O	139	142	are	be	VBP	B-VP
O	143	146	the	the	DT	B-NP
O	147	150	4th	4th	JJ	I-NP
O	151	155	most	most	RBS	I-NP
O	156	162	common	common	JJ	I-NP
O	163	168	cause	cause	NN	I-NP
O	169	171	of	of	IN	B-PP
O	172	182	nosocomial	nosocomial	JJ	B-NP
B-Organism_substance	183	194	bloodstream	bloodstream	NN	I-NP
O	195	205	infections	infection	NNS	I-NP
O	206	208	in	in	IN	B-PP
O	209	212	the	the	DT	B-NP
O	213	219	United	United	NNP	I-NP
O	220	226	States	State	NNPS	I-NP
O	226	227	,	,	,	O
O	228	231	and	and	CC	O
O	232	244	Cryptococcus	Cryptococcus	NNP	B-NP
O	245	255	neoformans	neoforman	NNS	I-NP
O	255	256	,	,	,	O
O	257	260	the	the	DT	B-NP
O	261	270	commonest	common	JJS	I-NP
O	271	276	cause	cause	NN	I-NP
O	277	279	of	of	IN	B-PP
O	280	286	fungal	fungal	JJ	B-NP
O	287	297	meningitis	meningitis	NN	I-NP
O	298	307	worldwide	worldwide	RB	B-ADVP
O	308	309	[	[	(	O
O	309	310	1	1	CD	B-NP
O	310	311	]	]	)	O
O	311	312	,	,	,	O
O	313	314	[	[	(	O
O	314	315	2	2	CD	B-NP
O	315	316	]	]	)	O
O	316	317	.	.	.	O

O	318	324	Whilst	Whilst	NNP	B-NP
O	325	332	Candida	Candida	NNP	I-NP
O	333	341	albicans	albicans	NNP	I-NP
O	342	349	remains	remain	VBZ	B-VP
O	350	353	the	the	DT	B-NP
O	354	361	leading	lead	VBG	I-NP
O	362	372	pathogenic	pathogenic	JJ	I-NP
O	373	378	yeast	yeast	NN	I-NP
O	378	379	,	,	,	O
O	380	390	infections	infection	NNS	B-NP
O	391	394	due	due	JJ	B-ADJP
O	395	397	to	to	TO	B-PP
O	398	401	non	non	AFX	B-NP
O	401	402	-	-	HYPH	I-NP
O	402	403	C	C	NN	I-NP
O	403	404	.	.	.	O
O	405	413	albicans	albican	VBZ	B-VP
O	414	421	species	specie	NNS	B-NP
O	422	426	such	such	JJ	B-PP
O	427	429	as	as	IN	I-PP
O	430	437	Candida	Candida	NNP	B-NP
O	438	446	glabrata	glabrata	NNS	I-NP
O	446	447	,	,	,	O
O	448	450	as	as	RB	B-CONJP
O	451	455	well	well	RB	I-CONJP
O	456	458	as	as	IN	I-CONJP
O	459	469	previously	previously	RB	B-NP
O	470	474	rare	rare	JJ	I-NP
O	475	487	opportunists	opportunist	NNS	I-NP
O	488	492	such	such	JJ	B-PP
O	493	495	as	as	IN	I-PP
O	496	508	Trichosporon	Trichosporon	NNP	B-NP
O	509	512	and	and	CC	I-NP
O	513	523	Geotrichum	Geotrichum	NNP	I-NP
O	524	531	species	specie	NNS	I-NP
O	531	532	,	,	,	O
O	533	536	are	be	VBP	B-VP
O	537	549	increasingly	increasingly	RB	I-VP
O	550	558	reported	report	VBN	I-VP
O	559	560	[	[	(	O
O	560	561	1	1	CD	B-NP
O	561	562	]	]	)	O
O	562	563	,	,	,	O
O	564	565	[	[	(	O
O	565	566	3	3	CD	B-NP
O	566	567	]	]	)	O
O	567	568	-	-	HYPH	O
O	568	569	[	[	(	O
O	569	570	6	6	CD	B-NP
O	570	571	]	]	)	O
O	571	572	.	.	.	O

O	573	578	Novel	Novel	JJ	B-NP
O	579	589	pathogenic	pathogenic	JJ	I-NP
O	590	597	Candida	Candida	NNP	I-NP
O	598	605	species	specie	NNS	I-NP
O	606	610	such	such	JJ	B-PP
O	611	613	as	as	IN	I-PP
O	614	621	Candida	Candida	NNP	B-NP
O	622	633	nivariensis	nivariensis	NN	I-NP
O	634	637	and	and	CC	O
O	638	645	Candida	Candida	NNP	B-NP
O	646	657	bracarensis	bracarensis	NN	I-NP
O	658	662	have	have	VBP	B-VP
O	663	667	also	also	RB	I-VP
O	668	672	been	be	VBN	I-VP
O	673	682	described	describe	VBN	I-VP
O	683	684	[	[	(	O
O	684	685	7	7	CD	B-NP
O	685	686	]	]	)	O
O	686	687	.	.	.	O

O	688	693	Since	Since	IN	B-SBAR
O	694	698	many	many	JJ	B-NP
O	699	702	non	non	AFX	I-NP
O	702	703	-	-	HYPH	I-NP
O	703	704	C	C	NN	I-NP
O	704	705	.	.	.	O
O	706	714	albicans	albican	VBZ	B-VP
O	715	722	Candida	Candida	NNP	B-NP
O	723	726	and	and	CC	O
O	727	730	non	non	AFX	B-NP
O	730	731	-	-	HYPH	I-NP
O	731	738	Candida	Candida	NNP	I-NP
O	739	745	yeasts	yeast	NNS	I-NP
O	746	749	are	be	VBP	B-VP
O	750	759	resistant	resistant	JJ	B-ADJP
O	760	762	or	or	CC	O
O	763	767	less	less	RBR	B-ADJP
O	768	779	susceptible	susceptible	JJ	I-ADJP
O	780	782	to	to	TO	B-PP
O	783	793	antifungal	antifungal	JJ	B-NP
O	794	800	agents	agent	NNS	I-NP
O	800	801	,	,	,	O
O	802	807	rapid	rapid	JJ	B-NP
O	808	816	accurate	accurate	JJ	I-NP
O	817	824	species	species	NN	I-NP
O	825	839	identification	identification	NN	I-NP
O	840	842	is	be	VBZ	B-VP
O	843	850	central	central	JJ	B-ADJP
O	851	853	to	to	TO	B-PP
O	854	860	timely	timely	JJ	B-NP
O	860	861	,	,	,	I-NP
O	862	871	effective	effective	JJ	I-NP
O	872	882	antifungal	antifungal	JJ	I-NP
O	883	890	therapy	therapy	NN	I-NP
O	891	892	[	[	(	O
O	892	893	3	3	CD	B-NP
O	893	894	]	]	)	O
O	894	895	-	-	HYPH	O
O	895	896	[	[	(	O
O	896	897	6	6	CD	B-NP
O	897	898	]	]	)	O
O	898	899	,	,	,	O
O	900	901	[	[	(	O
O	901	902	8	8	CD	B-NP
O	902	903	]	]	)	O
O	903	904	,	,	,	O
O	905	906	[	[	(	O
O	906	907	9	9	CD	B-NP
O	907	908	]	]	)	O
O	908	909	.	.	.	O

O	910	922	Conventional	Conventional	JJ	B-NP
O	923	933	phenotypic	phenotypic	JJ	I-NP
O	933	934	-	-	HYPH	I-NP
O	934	939	based	base	VBN	I-NP
O	940	947	methods	method	NNS	I-NP
O	948	951	for	for	IN	B-PP
O	952	957	yeast	yeast	NN	B-NP
O	958	972	identification	identification	NN	I-NP
O	972	973	,	,	,	O
O	974	981	however	however	RB	B-ADVP
O	981	982	,	,	,	O
O	983	986	are	be	VBP	B-VP
O	987	991	slow	slow	JJ	B-ADJP
O	992	993	(	(	(	O
O	993	995	24	24	CD	B-NP
O	995	996	-	-	HYPH	I-NP
O	996	998	72	72	CD	I-NP
O	999	1000	h	h	NN	I-NP
O	1000	1001	)	)	)	O
O	1001	1002	,	,	,	O
O	1003	1014	insensitive	insensitive	JJ	B-ADJP
O	1015	1018	and	and	CC	O
O	1019	1024	often	often	RB	B-ADJP
O	1025	1031	unable	unable	JJ	I-ADJP
O	1032	1034	to	to	TO	B-VP
O	1035	1043	identify	identify	VB	I-VP
O	1044	1048	more	more	RBR	B-NP
O	1049	1056	unusual	unusual	JJ	I-NP
O	1057	1064	species	specie	NNS	I-NP
O	1064	1065	.	.	.	O

O	1066	1073	Various	Various	JJ	B-NP
O	1074	1083	molecular	molecular	JJ	I-NP
O	1084	1094	techniques	technique	NNS	I-NP
O	1095	1104	including	include	VBG	B-PP
O	1105	1109	real	real	JJ	B-NP
O	1109	1110	-	-	HYPH	I-NP
O	1110	1114	time	time	NN	I-NP
O	1115	1118	PCR	PCR	NN	I-NP
O	1118	1119	,	,	,	O
O	1120	1123	DNA	DNA	NN	B-NP
O	1124	1132	sequence	sequence	NN	I-NP
O	1133	1141	analysis	analysis	NN	I-NP
O	1141	1142	,	,	,	O
O	1143	1153	microarray	microarray	NN	B-NP
O	1154	1162	analysis	analysis	NN	I-NP
O	1162	1163	,	,	,	O
O	1164	1167	and	and	CC	O
O	1168	1180	fluorescence	fluorescence	NN	B-NP
O	1181	1183	in	in	FW	B-PP
O	1183	1184	-	-	HYPH	B-NP
O	1184	1188	situ	situ	FW	I-NP
O	1189	1202	hybridization	hybridization	NN	I-NP
O	1203	1210	provide	provide	VBP	B-VP
O	1211	1219	accurate	accurate	JJ	B-NP
O	1220	1234	identification	identification	NN	I-NP
O	1235	1236	[	[	(	O
O	1236	1238	10	10	CD	B-NP
O	1238	1239	]	]	)	O
O	1239	1240	,	,	,	O
O	1241	1242	[	[	(	O
O	1242	1244	11	11	CD	B-NP
O	1244	1245	]	]	)	O
O	1246	1249	but	but	CC	O
O	1250	1253	are	be	VBP	B-VP
O	1254	1263	expensive	expensive	JJ	B-ADJP
O	1263	1264	,	,	,	O
O	1265	1272	require	require	VB	B-VP
O	1273	1284	substantial	substantial	JJ	B-NP
B-Cell	1285	1293	specimen	specimen	NN	I-NP
O	1294	1304	processing	processing	NN	I-NP
O	1305	1309	time	time	NN	I-NP
O	1310	1311	(	(	(	O
O	1311	1316	hours	hour	NNS	B-NP
O	1317	1319	to	to	TO	B-PP
O	1320	1321	a	a	DT	B-NP
O	1322	1325	day	day	NN	I-NP
O	1325	1326	)	)	)	O
O	1327	1330	and	and	CC	O
O	1331	1334	are	be	VBP	B-VP
O	1335	1338	not	not	RB	I-VP
O	1339	1345	easily	easily	RB	I-VP
O	1346	1357	implemented	implement	VBN	I-VP
O	1358	1360	as	as	IN	B-PP
O	1361	1368	routine	routine	JJ	B-NP
O	1369	1379	techniques	technique	NNS	I-NP
O	1380	1382	in	in	IN	B-PP
O	1383	1386	the	the	DT	B-NP
O	1387	1395	clinical	clinical	JJ	I-NP
O	1396	1406	laboratory	laboratory	NN	I-NP
O	1406	1407	.	.	.	O

O	1408	1414	Matrix	Matrix	NN	B-NP
O	1414	1415	-	-	HYPH	B-PP
O	1415	1423	assisted	assist	VBN	B-NP
O	1424	1429	laser	laser	NN	I-NP
O	1430	1440	desorption	desorption	NN	I-NP
O	1441	1451	ionization	ionization	NN	I-NP
O	1451	1452	-	-	HYPH	O
O	1452	1456	time	time	NN	B-NP
O	1457	1459	of	of	IN	B-PP
O	1460	1466	flight	flight	NN	B-NP
O	1467	1471	mass	mass	NN	I-NP
O	1472	1484	spectrometry	spectrometry	NN	I-NP
O	1485	1486	(	(	(	O
O	1486	1491	MALDI	MALDI	NN	B-NP
O	1491	1492	-	-	HYPH	B-NP
O	1492	1495	TOF	TOF	NN	I-NP
O	1496	1498	MS	MS	NN	I-NP
O	1498	1499	)	)	)	O
O	1500	1503	has	have	VBZ	B-VP
O	1504	1511	emerged	emerge	VBN	I-VP
O	1512	1514	as	as	IN	B-PP
O	1515	1516	a	a	DT	B-NP
O	1517	1525	powerful	powerful	JJ	I-NP
O	1526	1529	and	and	CC	I-NP
O	1530	1535	rapid	rapid	JJ	I-NP
O	1536	1540	tool	tool	NN	I-NP
O	1541	1544	for	for	IN	B-PP
O	1545	1548	the	the	DT	B-NP
O	1549	1563	identification	identification	NN	I-NP
O	1564	1566	of	of	IN	B-PP
O	1567	1576	bacterial	bacterial	JJ	B-NP
O	1577	1580	and	and	CC	I-NP
O	1581	1586	yeast	yeast	NN	I-NP
O	1587	1596	pathogens	pathogen	NNS	I-NP
O	1597	1598	[	[	(	O
O	1598	1600	12	12	CD	B-NP
O	1600	1601	]	]	)	O
O	1601	1602	-	-	HYPH	O
O	1602	1603	[	[	(	O
O	1603	1605	17	17	CD	B-NP
O	1605	1606	]	]	)	O
O	1606	1607	.	.	.	O

O	1608	1613	Using	Use	VBG	B-VP
O	1614	1619	MALDI	MALDI	NN	B-NP
O	1619	1620	-	-	HYPH	I-NP
O	1620	1623	TOF	TOF	NN	I-NP
O	1624	1626	MS	MS	NN	I-NP
O	1626	1627	,	,	,	O
O	1628	1631	the	the	DT	B-NP
O	1632	1639	protein	protein	NN	I-NP
O	1640	1648	spectral	spectral	JJ	I-NP
O	1649	1650	"	"	``	I-NP
O	1650	1661	fingerprint	fingerprint	NN	I-NP
O	1661	1662	"	"	''	O
O	1663	1665	of	of	IN	B-PP
O	1666	1668	an	an	DT	B-NP
O	1669	1676	isolate	isolate	NN	I-NP
O	1677	1679	is	be	VBZ	B-VP
O	1680	1688	compared	compare	VBN	I-VP
O	1689	1691	to	to	TO	B-PP
O	1692	1693	a	a	DT	B-NP
O	1694	1703	reference	reference	NN	I-NP
O	1704	1712	spectral	spectral	JJ	I-NP
O	1713	1721	database	database	NN	I-NP
O	1722	1725	for	for	IN	B-PP
O	1726	1740	identification	identification	NN	B-NP
O	1741	1742	[	[	(	O
O	1742	1744	18	18	CD	B-NP
O	1744	1745	]	]	)	O
O	1745	1746	.	.	.	O

O	1747	1755	Previous	Previous	JJ	B-NP
O	1756	1763	studies	study	NNS	I-NP
O	1764	1768	have	have	VBP	B-VP
O	1769	1777	reported	report	VBN	I-VP
O	1778	1785	species	specie	NNS	B-NP
O	1786	1800	identification	identification	NN	I-NP
O	1801	1806	rates	rate	NNS	I-NP
O	1807	1809	of	of	IN	B-PP
O	1810	1812	92	92	CD	B-NP
O	1812	1813	-	-	HYPH	I-NP
O	1813	1815	99	99	CD	I-NP
O	1815	1816	%	%	NN	I-NP
O	1817	1824	amongst	amongst	IN	B-PP
O	1825	1836	collections	collection	NNS	B-NP
O	1837	1839	of	of	IN	B-PP
O	1840	1846	yeasts	yeast	NNS	B-NP
O	1847	1850	and	and	CC	I-NP
O	1851	1856	yeast	yeast	NN	I-NP
O	1856	1857	-	-	HYPH	O
O	1857	1861	like	like	JJ	B-NP
O	1862	1871	organisms	organism	NNS	I-NP
O	1872	1873	[	[	(	O
O	1873	1875	14	14	CD	B-NP
O	1875	1876	]	]	)	O
O	1876	1877	-	-	HYPH	O
O	1877	1878	[	[	(	O
O	1878	1880	17	17	CD	B-NP
O	1880	1881	]	]	)	O
O	1881	1882	,	,	,	O
O	1883	1884	[	[	(	O
O	1884	1886	19	19	CD	B-NP
O	1886	1887	]	]	)	O
O	1887	1888	,	,	,	O
O	1889	1890	[	[	(	O
O	1890	1892	20	20	CD	B-NP
O	1892	1893	]	]	)	O
O	1893	1894	.	.	.	O

O	1895	1902	However	However	RB	B-ADVP
O	1902	1903	,	,	,	O
O	1904	1909	taken	take	VBN	B-VP
O	1910	1922	collectively	collectively	RB	B-ADVP
O	1922	1923	,	,	,	O
O	1924	1927	the	the	DT	B-NP
O	1928	1935	results	result	NNS	I-NP
O	1936	1939	may	may	MD	B-VP
O	1940	1943	not	not	RB	I-VP
O	1944	1946	be	be	VB	I-VP
O	1947	1955	directly	directly	RB	B-ADJP
O	1956	1966	comparable	comparable	JJ	I-ADJP
O	1967	1972	since	since	IN	B-SBAR
O	1973	1978	these	these	DT	B-NP
O	1979	1986	studies	study	NNS	I-NP
O	1987	1991	have	have	VBP	B-VP
O	1992	1996	used	use	VBN	I-VP
O	1997	2006	different	different	JJ	B-NP
O	2007	2017	approaches	approach	NNS	I-NP
O	2018	2020	to	to	TO	B-VP
O	2021	2027	assign	assign	VB	I-VP
O	2028	2035	species	species	NN	B-NP
O	2036	2037	-	-	HYPH	B-ADJP
O	2038	2042	from	from	IN	B-PP
O	2043	2052	comparing	compare	VBG	B-VP
O	2053	2060	spectra	spectrum	NNS	B-NP
O	2061	2065	from	from	IN	B-PP
O	2066	2070	test	test	NN	B-NP
O	2071	2080	organisms	organism	NNS	I-NP
O	2081	2083	to	to	TO	B-PP
O	2084	2093	reference	reference	NN	B-NP
O	2094	2101	spectra	spectrum	NNS	I-NP
O	2102	2104	in	in	IN	B-PP
O	2105	2110	MALDI	MALDI	NN	B-NP
O	2110	2111	-	-	HYPH	B-NP
O	2111	2114	TOF	TOF	NN	I-NP
O	2115	2117	MS	MS	NN	I-NP
O	2118	2127	databases	database	NNS	I-NP
O	2128	2129	[	[	(	O
O	2129	2131	16	16	CD	B-NP
O	2131	2132	]	]	)	O
O	2132	2133	,	,	,	O
O	2134	2135	[	[	(	O
O	2135	2137	20	20	CD	B-NP
O	2137	2138	]	]	)	O
O	2138	2139	,	,	,	O
O	2140	2142	to	to	TO	B-PP
O	2143	2152	enhancing	enhance	VBG	B-VP
O	2153	2158	these	these	DT	B-NP
O	2159	2168	databases	database	NNS	I-NP
O	2168	2169	,	,	,	O
O	2170	2173	and	and	CC	O
O	2174	2176	in	in	IN	B-PP
O	2177	2181	some	some	DT	B-NP
O	2182	2191	instances	instance	NNS	I-NP
O	2192	2202	developing	develop	VBG	B-VP
O	2203	2208	study	study	NN	B-NP
O	2208	2209	-	-	HYPH	B-NP
O	2209	2217	specific	specific	JJ	I-NP
O	2218	2227	databases	database	NNS	I-NP
O	2227	2228	,	,	,	O
O	2229	2233	with	with	IN	B-PP
O	2234	2235	"	"	``	O
O	2235	2237	in	in	IN	B-PP
O	2237	2238	-	-	HYPH	B-NP
O	2238	2243	house	house	NN	I-NP
O	2243	2244	"	"	''	O
O	2245	2253	spectral	spectral	JJ	B-NP
O	2254	2264	signatures	signature	NNS	I-NP
O	2265	2266	[	[	(	O
O	2266	2268	14	14	CD	B-NP
O	2268	2269	]	]	)	O
O	2269	2270	,	,	,	O
O	2271	2272	[	[	(	O
O	2272	2274	15	15	CD	B-NP
O	2274	2275	]	]	)	O
O	2275	2276	.	.	.	O

O	2277	2282	There	There	EX	B-NP
O	2283	2287	also	also	RB	B-ADVP
O	2288	2290	is	be	VBZ	B-VP
O	2291	2292	a	a	DT	B-NP
O	2293	2303	continuing	continue	VBG	I-NP
O	2304	2308	need	need	NN	I-NP
O	2309	2311	to	to	TO	B-VP
O	2312	2318	extend	extend	VB	I-VP
O	2319	2322	the	the	DT	B-NP
O	2323	2333	repository	repository	NN	I-NP
O	2334	2336	of	of	IN	B-PP
O	2337	2346	reference	reference	NN	B-NP
O	2347	2354	spectra	spectrum	NNS	I-NP
O	2355	2357	in	in	IN	B-PP
O	2358	2363	MALDI	MALDI	NN	B-NP
O	2363	2364	-	-	HYPH	B-NP
O	2364	2367	TOF	TOF	NN	I-NP
O	2368	2370	MS	MS	NN	I-NP
O	2371	2380	databases	database	NNS	I-NP
O	2380	2381	.	.	.	O

O	2382	2384	We	We	PRP	B-NP
O	2385	2394	therefore	therefore	RB	B-ADVP
O	2395	2404	undertook	undertake	VBD	B-VP
O	2405	2408	the	the	DT	B-NP
O	2409	2416	present	present	JJ	I-NP
O	2417	2422	study	study	NN	I-NP
O	2423	2425	to	to	TO	B-VP
O	2426	2434	evaluate	evaluate	VB	I-VP
O	2435	2438	the	the	DT	B-NP
O	2439	2446	utility	utility	NN	I-NP
O	2447	2449	of	of	IN	B-PP
O	2450	2453	the	the	DT	B-NP
O	2454	2459	MALDI	MALDI	NNP	I-NP
O	2460	2468	Biotyper	Biotyper	NNP	I-NP
O	2469	2470	2	2	CD	I-NP
O	2470	2471	.	.	.	O
O	2471	2472	0	0	CD	B-NP
O	2473	2482	Microflex	Microflex	NNP	I-NP
O	2483	2485	LT	LT	NNP	I-NP
O	2486	2498	spectrometer	spectrometer	NN	I-NP
O	2499	2500	(	(	(	O
O	2500	2506	Bruker	Bruker	NNP	B-NP
O	2507	2515	Daltonik	Daltonik	NNP	I-NP
O	2516	2520	GmbH	GmbH	NNP	I-NP
O	2520	2521	;	;	:	O
O	2522	2528	Bremen	Bremen	NNP	B-NP
O	2528	2529	,	,	,	O
O	2530	2537	Germany	Germany	NNP	B-NP
O	2537	2538	)	)	)	O
O	2539	2543	with	with	IN	B-PP
O	2544	2547	its	its	PRP$	B-NP
O	2548	2555	current	current	JJ	I-NP
O	2556	2564	spectral	spectral	JJ	I-NP
O	2565	2573	database	database	NN	I-NP
O	2574	2576	in	in	IN	B-PP
O	2577	2587	comparison	comparison	NN	B-NP
O	2588	2592	with	with	IN	B-PP
O	2593	2603	phenotypic	phenotypic	JJ	B-NP
O	2603	2604	-	-	HYPH	I-NP
O	2604	2609	based	base	VBN	I-NP
O	2610	2617	methods	method	NNS	I-NP
O	2618	2621	for	for	IN	B-PP
O	2622	2625	the	the	DT	B-NP
O	2626	2640	identification	identification	NN	I-NP
O	2641	2643	of	of	IN	B-PP
O	2644	2645	a	a	DT	B-NP
O	2646	2651	broad	broad	JJ	I-NP
O	2652	2657	range	range	NN	I-NP
O	2658	2660	of	of	IN	B-PP
O	2661	2667	yeasts	yeast	NNS	B-NP
O	2668	2670	in	in	IN	B-PP
O	2671	2672	a	a	DT	B-NP
O	2673	2683	diagnostic	diagnostic	JJ	I-NP
O	2684	2694	laboratory	laboratory	NN	I-NP
O	2694	2695	.	.	.	O

O	2696	2699	The	The	DT	B-NP
O	2700	2705	first	first	JJ	I-NP
O	2706	2710	part	part	NN	I-NP
O	2711	2713	of	of	IN	B-PP
O	2714	2717	the	the	DT	B-NP
O	2718	2723	study	study	NN	I-NP
O	2724	2733	comprised	comprise	VBD	B-VP
O	2734	2741	testing	testing	NN	B-NP
O	2742	2744	of	of	IN	B-PP
O	2745	2754	reference	reference	NN	B-NP
O	2755	2758	and	and	CC	O
O	2759	2767	clinical	clinical	JJ	B-NP
B-Cell	2768	2775	strains	strain	NNS	I-NP
O	2776	2780	from	from	IN	B-PP
O	2781	2784	our	our	PRP$	B-NP
O	2785	2792	culture	culture	NN	I-NP
O	2793	2803	collection	collection	NN	I-NP
O	2803	2804	.	.	.	O

O	2805	2808	The	The	DT	B-NP
O	2809	2815	second	second	NN	I-NP
O	2816	2819	was	be	VBD	B-VP
O	2820	2821	a	a	DT	B-NP
O	2822	2829	blinded	blinded	JJ	I-NP
O	2830	2841	prospective	prospective	JJ	I-NP
O	2842	2850	analysis	analysis	NN	I-NP
O	2851	2853	of	of	IN	B-PP
O	2854	2861	freshly	freshly	RB	B-NP
O	2861	2862	-	-	HYPH	I-NP
O	2862	2871	collected	collect	VBN	I-NP
O	2872	2877	yeast	yeast	NN	I-NP
O	2878	2886	isolates	isolate	NNS	I-NP
O	2887	2896	recovered	recover	VBN	B-VP
O	2897	2903	during	during	IN	B-PP
O	2904	2911	routine	routine	JJ	B-NP
O	2912	2922	laboratory	laboratory	NN	I-NP
O	2923	2927	work	work	NN	I-NP
O	2928	2932	flow	flow	NN	I-NP
O	2932	2933	;	;	:	O
O	2934	2944	discrepant	discrepant	JJ	B-NP
O	2945	2952	results	result	NNS	I-NP
O	2953	2960	between	between	IN	B-PP
O	2961	2966	MALDI	MALDI	NN	B-NP
O	2967	2970	TOF	TOF	NN	I-NP
O	2971	2973	MS	MS	NN	I-NP
O	2974	2977	and	and	CC	O
O	2978	2988	phenotypic	phenotypic	JJ	B-NP
O	2989	2996	methods	method	NNS	I-NP
O	2997	3001	were	be	VBD	B-VP
O	3002	3010	resolved	resolve	VBN	I-VP
O	3011	3016	using	use	VBG	B-VP
O	3017	3025	sequence	sequence	NN	B-NP
O	3026	3034	analysis	analysis	NN	I-NP
O	3035	3037	of	of	IN	B-PP
O	3038	3041	the	the	DT	B-NP
O	3042	3048	fungal	fungal	JJ	I-NP
O	3049	3057	internal	internal	JJ	I-NP
O	3058	3069	transcribed	transcribe	VBN	I-NP
O	3070	3076	spacer	spacer	NN	I-NP
O	3077	3078	(	(	(	O
O	3078	3081	ITS	ITS	NNS	B-NP
O	3081	3082	)	)	)	O
O	3083	3090	regions	region	NNS	B-NP
O	3091	3092	[	[	(	O
O	3092	3094	21	21	CD	B-NP
O	3094	3095	]	]	)	O
O	3095	3096	,	,	,	O
O	3097	3098	[	[	(	O
O	3098	3100	22	22	CD	B-NP
O	3100	3101	]	]	)	O
O	3101	3102	.	.	.	O

O	3103	3110	Results	Result	NNS	B-NP
O	3111	3119	obtained	obtain	VBN	B-VP
O	3120	3122	by	by	IN	B-PP
O	3123	3134	preparation	preparation	NN	B-NP
O	3135	3137	of	of	IN	B-PP
O	3138	3144	yeasts	yeast	NNS	B-NP
O	3145	3147	by	by	IN	B-PP
O	3148	3158	extraction	extraction	NN	B-NP
O	3159	3161	of	of	IN	B-PP
O	3162	3168	fungal	fungal	JJ	B-NP
O	3169	3177	proteins	protein	NNS	I-NP
O	3178	3181	and	and	CC	B-PP
O	3182	3184	by	by	IN	B-PP
O	3185	3191	direct	direct	JJ	B-NP
O	3192	3203	application	application	NN	I-NP
O	3204	3206	of	of	IN	B-PP
O	3207	3212	yeast	yeast	NN	B-NP
B-Cell	3213	3221	colonies	colony	NNS	I-NP
O	3222	3226	onto	onto	IN	B-PP
O	3227	3230	the	the	DT	B-NP
O	3231	3236	MALDI	MALDI	NNP	I-NP
O	3237	3240	TOF	TOF	NN	I-NP
O	3241	3243	MS	MS	NN	I-NP
O	3244	3249	plate	plate	NN	I-NP
O	3250	3254	were	be	VBD	B-VP
O	3255	3259	also	also	RB	I-VP
O	3260	3268	compared	compare	VBN	I-VP
O	3268	3269	.	.	.	O

